Tissue repair

组织修复
  • 文章类型: Journal Article
    再生医学,包括旨在组织修复和再生的各种治疗方法,已经成为物理治疗领域的一个有前途的领域。目的:这篇全面的综述旨在探索再生医学在物理治疗领域中不断发展的作用。强调其潜在的应用,挑战,和当前的趋势。研究人员选择了2015年至2024年的相关研究出版物,并对PubMed等电子数据库进行了详尽的审查。Embase,和谷歌学者使用有针对性的关键词“再生医学”,“康复”,“组织修复”,和“物理治疗”根据预设的合格参数筛选适用的研究,然后从提取的数据中编译关键见解。在物理治疗中应用的几种再生医学方法,特别是,干细胞疗法,富血小板血浆(PRP),组织工程,和生长因子治疗,在这项研究中进行了分析。阐述了这些方法在回收过程中的相应功效,包括关于促进组织修复的讨论,减轻疼痛,改善功能恢复。此外,这篇综述报告了有关再生疗法的挑战,其中协议的标准化,安全问题,和伦理问题。再生医学作为物理疗法的辅助疗法具有相当大的潜力,为改善组织修复和功能结果提供新的途径。尽管在解释再生技术的潜力方面取得了重大进展,需要进一步的研究来加强协议,建立安全概况,并增加访问和可用性。将再生医学纳入物理疗法的结构表明临床实践发生了革命性的变化,与增加患者护理和改善长期结果的好处。
    Regenerative medicine, encompassing various therapeutic approaches aimed at tissue repair and regeneration, has emerged as a promising field in the realm of physical therapy. Aim: This comprehensive review seeks to explore the evolving role of regenerative medicine within the domain of physical therapy, highlighting its potential applications, challenges, and current trends. Researchers selected publications of pertinent studies from 2015 to 2024 and performed an exhaustive review of electronic databases such as PubMed, Embase, and Google Scholar using the targeted keywords \"regenerative medicine\", \"rehabilitation\", \"tissue repair\", and \"physical therapy\" to screen applicable studies according to preset parameters for eligibility, then compiled key insights from the extracted data. Several regenerative medicine methods that are applied in physical therapy, in particular, stem cell therapy, platelet-rich plasma (PRP), tissue engineering, and growth factor treatments, were analyzed in this research study. The corresponding efficacy of these methods in the recovery process were also elaborated, including a discussion on facilitating tissue repair, alleviating pain, and improving functional restoration. Additionally, this review reports the challenges concerning regenerative therapies, among them the standardization of protocols, safety concerns, and ethical issues. Regenerative medicine bears considerable potential as an adjunctive therapy in physiotherapy, providing new pathways for improving tissue repair and functional results. Although significant strides have been made in interpreting the potential of regenerative techniques, further research is warranted to enhance protocols, establish safety profiles, and increase access and availability. Merging regenerative medicine into the structure of physical therapy indicates a transformative alteration in clinical practice, with the benefit of increasing patient care and improving long-term results.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    近年来,微载体在组织工程中的应用取得了长足的进步,可以加载细胞,毒品,和生物活性因子。这些微载体可以最低限度地注射到缺损中,以帮助重建用于组织修复的良好微环境。为了达到更理想的性能,面对更复杂的组织损伤,越来越多的努力集中在可以主动响应外部刺激的微载体上。这些微载体具有定向运动的功能,定向富集,材料释放控制,并提供有利于组织修复的信号。鉴于磁性和电活性微载体的高可控性和可设计性,本文重点介绍了这些微载体的研究进展。他们的结构,功能和应用,潜在的组织修复机制,并讨论了挑战。总之,通过具有临床翻译能力的设计,有意义和全面的实验表征,以及组织修复机制的深入研究和应用,刺激响应性微载体在组织修复中具有巨大潜力。
    Microcarrier applications have made great advances in tissue engineering in recent years, which can load cells, drugs, and bioactive factors. These microcarriers can be minimally injected into the defect to help reconstruct a good microenvironment for tissue repair. In order to achieve more ideal performance and face more complex tissue damage, an increasing amount of effort has been focused on microcarriers that can actively respond to external stimuli. These microcarriers have the functions of directional movement, targeted enrichment, material release control, and providing signals conducive to tissue repair. Given the high controllability and designability of magnetic and electroactive microcarriers, the research progress of these microcarriers is highlighted in this review. Their structure, function and applications, potential tissue repair mechanisms, and challenges are discussed. In summary, through the design with clinical translation ability, meaningful and comprehensive experimental characterization, and in-depth study and application of tissue repair mechanisms, stimuli-responsive microcarriers have great potential in tissue repair.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    受损组织或器官的修复和再生是生物医学的主要挑战。以及新兴的3D生物打印技术,作为生物医学研究中的一类有前途的技术,用于组织工程和再生医学的发展。基于壳聚糖的生物墨水,作为天然生物材料,由于其独特的动态可逆性和出色的生物学特性,被认为是3D生物打印设计和制造各种支架的理想材料。我们的综述旨在为体外组织修复和再生提供基于壳聚糖的生物墨水的概述。从影响这些生物打印过程的壳聚糖改性开始。此外,我们总结了壳聚糖基生物墨水在各种3D打印策略中的应用进展。此外,讨论了壳聚糖基生物墨水的生物医学应用,主要集中在再生医学和组织建模工程。最后,讨论了该领域当前的挑战和未来的机遇。基于壳聚糖的生物墨水和3D生物打印的结合将有望开发用于组织或器官修复和再生的新型生物医学支架。
    The repair and regeneration of the injured tissues or organs is a major challenge for biomedicine, and the emerging 3D bioprinting technology as a class of promising techniques in biomedical research for the development of tissue engineering and regenerative medicine. Chitosan-based bioinks, as the natural biomaterials, are considered as ideal materials for 3D bioprinting to design and fabricate the various scaffold due to their unique dynamic reversibility and fantastic biological properties. Our review aims to provide an overview of chitosan-based bioinks for in vitro tissue repair and regeneration, starting from modification of chitosan that affect these bioprinting processes. In addition, we summarize the advances in chitosan-based bioinks used in the various 3D printing strategies. Moreover, the biomedical applications of chitosan-based bioinks are discussed, primarily centered on regenerative medicine and tissue modeling engineering. Finally, current challenges and future opportunities in this field are discussed. The combination of chitosan-based bioinks and 3D bioprinting will hold promise for developing novel biomedical scaffolds for tissue or organ repair and regeneration.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    近年来,越来越多的科学家专注于进行激光消融骨组织的实验。本研究的目的是总结过去硬组织消融实验中组织的预后和热损伤的程度,并对激光截骨手术可行性的证据进行综述。PubMed的电子搜索,中国国家知识基础设施(CNKI),和WebofScience(WOS)在2023年6月之前发表了相关的英语文章。这篇综述包括48篇从医学和生物学角度对硬组织进行激光消融的文献报道。它总结了以前的研究,其中理想的消融率,消融深度,通过改变激光类型,对骨组织和周围软组织的损伤最小,优化激光参数设置,或添加佐剂装置。通过观察其术后愈合和炎症反应,这篇综述旨在提供对脉冲激光消融硬组织的更好理解。先前的研究表明,激光截骨术在骨切除手术中取得了令人鼓舞的结果。我们认为,通过实验选择合适的激光器类型,可以实现低甚至没有热损伤,优化激光参数,如脉冲持续时间和频率,或增加额外的辅助冷却装置。然而,缺乏临床研究使得很难最终确定激光截骨术在临床应用中是否优越。
    In recent years, an increasing number of scientists have focused on conducting experiments on laser ablation of bone tissue. The purpose of this study was to summarize the prognosis of tissue and the extent of thermal damage in past hard tissue ablation experiments, and review the evidence for the feasibility of laser osteotomy in surgery. An electronic search of PubMed, China National Knowledge Infrastructure (CNKI), and Web of Science (WOS) for relevant English-language articles published through June 2023 was conducted. This review includes 48 literature reports on laser ablation of hard tissues from medical and biological perspectives. It summarizes previous studies in which the ideal ablation rate, depth of ablation, and minimal damage to bone tissue and surrounding soft tissues were achieved by changing the laser type, optimizing the laser parameter settings, or adding adjuvant devices. By observing their post-operative healing and inflammatory response, this review aims to provide a better understanding of pulsed laser ablation of hard tissues. Previous studies suggest that laser osteotomy has yielded encouraging results in bone resection procedures. We believe that low or even no thermal damage can be achieved by experimentally selecting a suitable laser type, optimizing laser parameters such as pulse duration and frequency, or adding additional auxiliary cooling devices. However, the lack of clinical studies makes it difficult to conclusively determine whether laser osteotomy is superior in clinical applications.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    关于特定大分子及其对组织修复的贡献有许多研究。大分子对生物体有支持和保护作用,可以帮助再生,重塑,促进受损组织的自我修复和再生。大分子,如蛋白质,核酸,和多糖,可以构建成用于制备缓释药物的水凝胶,细胞培养载体,和基因传递平台。水凝胶和微球是通过化学交联或混合共沉积制成的,通常用作支架,药物携带者,或细胞培养基质,提供适当的机械支持和营养输送,一个良好的环境,以促进受损组织的再生和修复。这篇综述全面概述了基于蛋白质的水凝胶和微球构建大分子的最新进展,核酸,多糖和其他聚合物及其在组织修复中的应用。然后,我们讨论了有关这些复合材料在修复组织中的优缺点的最新研究趋势。Further,我们研究了微球/水凝胶在不同组织修复中的应用,如皮肤组织,软骨,肿瘤组织,滑膜,神经组织,和心脏修复。该综述最后强调了微球/水凝胶复合材料的挑战和前景。
    There are many studies on specific macromolecules and their contributions to tissue repair. Macromolecules have supporting and protective effects in organisms and can help regrow, reshape, and promote self-repair and regeneration of damaged tissues. Macromolecules, such as proteins, nucleic acids, and polysaccharides, can be constructed into hydrogels for the preparation of slow-release drug agents, carriers for cell culture, and platforms for gene delivery. Hydrogels and microspheres are fabricated by chemical crosslinking or mixed co-deposition often used as scaffolds, drug carriers, or cell culture matrix, provide proper mechanical support and nutrient delivery, a well-conditioned environment that to promote the regeneration and repair of damaged tissues. This review provides a comprehensive overview of recent developments in the construction of macromolecules into hydrogels and microspheres based on the proteins, nucleic acids, polysaccharides and other polymer and their application in tissue repair. We then discuss the latest research trends regarding the advantages and disadvantages of these composites in repair tissue. Further, we examine the applications of microspheres/hydrogels in different tissue repairs, such as skin tissue, cartilage, tumor tissue, synovial, nerve tissue, and cardiac repair. The review closes by highlighting the challenges and prospects of microspheres/hydrogels composites.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    血管生成是从现有血管形成新血管,并且是在愈合和变性组织中的慢性紊乱之后的组织修复中的关键的第一步。慢性病理解剖组织的特征是大量的炎症细胞;炎症介质的过度表达;如肿瘤坏死因子-α(TNF-α)和白细胞介素-1(IL-1);肥大细胞的存在,T细胞,活性氧,和基质金属蛋白酶;和降低的血管生成能力。多项研究表明,自体体态生物学细胞制剂(例如,富血小板血浆(PRP))改善组织修复和再生组织。市场上有许多PRP设备。不幸的是,它们的血小板数量差异很大,细胞组成,和生物制剂。PRP是一种由高浓度血小板组成的血小板浓缩物,有或没有某些白细胞,血小板衍生生长因子(PGFs),细胞因子,分子,和信号细胞。几种PRP产品具有免疫调节能力,可以影响患病微环境中的常驻细胞。诱导组织修复或再生。一般来说,PRP是一种血液衍生产品,不管它的血小板数量和生物制剂,文献显示患者治疗结果为阳性和阴性.奇怪的是,文献没有指定可能有助于组织修复的特定PRP制备资格.此外,文献很少讨论PRP中血小板和白细胞对(新)血管生成的影响,除了“PRP具有血管生成能力”的通用一刀切的声明之外。这里,我们回顾了所有PRP成分的细胞组成,包括白细胞,并描述了血小板给药和生物制剂策略在体态生物学应用中的重要性,以启动重新建立微血管网络的血管生成途径,促进氧气和营养向受损组织的供应。
    Angiogenesis is the formation of new blood vessel from existing vessels and is a critical first step in tissue repair following chronic disturbances in healing and degenerative tissues. Chronic pathoanatomic tissues are characterized by a high number of inflammatory cells; an overexpression of inflammatory mediators; such as tumor necrosis factor-α (TNF-α) and interleukin-1 (IL-1); the presence of mast cells, T cells, reactive oxygen species, and matrix metalloproteinases; and a decreased angiogenic capacity. Multiple studies have demonstrated that autologous orthobiological cellular preparations (e.g., platelet-rich plasma (PRP)) improve tissue repair and regenerate tissues. There are many PRP devices on the market. Unfortunately, they differ greatly in platelet numbers, cellular composition, and bioformulation. PRP is a platelet concentrate consisting of a high concentration of platelets, with or without certain leukocytes, platelet-derived growth factors (PGFs), cytokines, molecules, and signaling cells. Several PRP products have immunomodulatory capacities that can influence resident cells in a diseased microenvironment, inducing tissue repair or regeneration. Generally, PRP is a blood-derived product, regardless of its platelet number and bioformulation, and the literature indicates both positive and negative patient treatment outcomes. Strangely, the literature does not designate specific PRP preparation qualifications that can potentially contribute to tissue repair. Moreover, the literature scarcely addresses the impact of platelets and leukocytes in PRP on (neo)angiogenesis, other than a general one-size-fits-all statement that \"PRP has angiogenic capabilities\". Here, we review the cellular composition of all PRP constituents, including leukocytes, and describe the importance of platelet dosing and bioformulation strategies in orthobiological applications to initiate angiogenic pathways that re-establish microvasculature networks, facilitating the supply of oxygen and nutrients to impaired tissues.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    脊髓损伤(SCI)是一种通常由意外事故引起的中枢神经系统疾病,其预后并不令人满意,对患者生活有长期不利影响。其治疗的关键在于损伤时微环境的改善和轴突的重建,组织修复是一种有前途的治疗策略。水凝胶是一种高含水量的三维网状结构,具有生物相容性的优点,降解性,和可调性,并可用于通过可注射的流动亲水材料原位填充病理缺陷,以准确适应损伤的大小和形状。水凝胶模拟细胞定植的天然细胞外基质,引导轴突延伸,充当生物支架,可作为优良的载体参与SCI的治疗。添加不同材料制备复合水凝胶支架可以进一步增强其各方面性能。在本文中,本文介绍了几种典型的复合水凝胶,综述了水凝胶治疗SCI的研究进展,以期为水凝胶治疗SCI的临床应用提供参考。
    Spinal cord injury (SCI) is a disease of the central nervous system often caused by accidents, and its prognosis is unsatisfactory, with long-term adverse effects on patients\' lives. The key to its treatment lies in the improvement of the microenvironment at the injury and the reconstruction of axons, and tissue repair is a promising therapeutic strategy. Hydrogel is a three-dimensional mesh structure with high water content, which has the advantages of biocompatibility, degradability, and adjustability, and can be used to fill pathological defects by injectable flowing hydrophilic material in situ to accurately adapt to the size and shape of the injury. Hydrogels mimic the natural extracellular matrix for cell colonization, guide axon extension, and act as a biological scaffold, which can be used as an excellent carrier to participate in the treatment of SCI. The addition of different materials to make composite hydrogel scaffolds can further enhance their performance in all aspects. In this paper, we introduce several typical composite hydrogels and review the research progress of hydrogel for SCI to provide a reference for the clinical application of hydrogel therapy for SCI.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    温度敏感的药物递送系统(TSDDS)是近年来由于其优点而在医学科学中受到更多关注的系统之一。由于这些系统对温度敏感,药物递送到目标变得更加具体。温度敏感型纳米凝胶有许多应用,包括微生物感染,癌症治疗,透皮使用和组织修复。这些系统的特点是毒性最小,改善治疗效果和减少暴露于正常细胞。这篇迷你评论是用不同类型的温度敏感纳米凝胶形成制备的,释放机制,以及它们的不同应用。在这些类别下报告的针对不同类别药物的靶向和控制递送的各种系统,如抗癌和抗生素药物,特别强调抗癌药物和组织愈合,在这个迷你评论中讨论。
    Temperature-sensitive drug delivery systems (TSDDS) are one of the systems that have received more attention in medical science these days due to their advantages. As these systems are sensitive to temperature, drug delivery to the target becomes more specific. Temperature-sensitive nanogels have many applications, including microbial infections, cancer therapy, transdermal use, and tissue repair. These systems are characterized by minimal toxicity, improved therapeutic efficacy, and reduced exposure to normal cells. This mini-review is prepared with different types of temperature-sensitive nanogel formation, release mechanisms, and their different applications. Various systems reported under these categories for targeted and controlled delivery of different classes of drugs, such as anti-cancer and antibiotic drugs with special emphasis on anti-cancer drugs and tissue healing, are discussed in this mini-review.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • DOI:
    文章类型: Review
    来自血液样品离心的血浆制剂,如富血小板血浆(PRP)和富血小板纤维蛋白(PRF),已被证明可用于治疗牙龈衰退,因为它们丰富的细胞浓度和细胞因子是软组织和硬组织修复机制的基础。根据用于生成PRP和PRF的制备方法,可以获得不同浓度的等离子体元素和物理化学特性。本研究旨在进行综合文献综述,以汇编有关产生等离子体制剂及其适应症的不同方案的可用数据。好处,和结果。采用描述性研究方法评估有关获得PRF的过程的文献,并搜索了MEDLINE数据库中索引的文章。文献综述表明,用于获得血液浓缩物的PRF方案的变化已导致更好地分离细胞和生长因子,并在组织修复中获得更有希望的结果。方案的演变导致具有不同成分的各种形式的PRF:(1)聚集血小板和白细胞的膜(L-PRF);(2)富含生长因子和细胞因子的PRF,称为高级PRF(A-PRF);(3)称为可注射PRF(I-PRF)的液相,其显示出比L-PRF更大的细胞积累;(4)A-PRF加(A-PDF),在10天的时间内改善了生长因子的释放;(5)通过渐进移液获得的浓缩PRF(C-PRF),在所有类型的血小板聚集体中具有最大的细胞积累。随后,观察到离心速度影响特定细胞的获取,导致了低速离心概念的发展。然后,确定相对离心力的减少显着增加了血小板的数量,白细胞,和增长因素。最近,离心角度的评估显示更大的大细胞截留,比如红细胞,当离心从固定角度更改为水平角度时。组织生物工程研究允许在获得血液成分的过程中取得重大进展,并使其能够以更高的可预测性和更低的发病率用于组织修复。
    Plasma preparations originating from the centrifugation of blood samples, such as platelet-rich plasma (PRP) and platelet-rich fibrin (PRF), have proven useful for the treatment of gingival recession due to their rich concentration of cells and cytokines fundamental in the mechanisms of both soft tissue and hard tissue repair. Depending on the preparation method used to generate PRP and PRF, different concentrations of plasma elements and physicochemical characteristics can be obtained. This study sought to perform an integrative literature review to compile the available data on different protocols for generating plasma preparations and their indications, benefits, and results. A descriptive research method was adopted for assessing the literature on processes for obtaining PRF, and articles indexed in the MEDLINE database were searched. The literature review showed that changes in the PRF protocols for obtaining blood concentrates have led to better isolation of cells and growth factors and more promising results in tissue repair. The evolution in protocols has resulted in various forms of PRF with different components: (1) a membrane that aggregates platelets and leukocytes (L-PRF); (2) a PRF rich in growth factors and cytokines, known as advanced PRF (A-PRF); (3) a liquid phase called injectable PRF (I-PRF) that shows greater cell accumulation than L-PRF; (4) A-PRF plus (A-PDF+), which improved the release of growth factors for a period of 10 days; and (5) concentrated PRF (C-PRF) obtained by progressive pipetting, which has the greatest cell accumulation among all of the types of platelet aggregates. Subsequently, the observation that the speed of centrifugation influenced the acquisition of specific cells resulted in the development of the low-speed centrifugation concept. Then, it was determined that reduction of the relative centrifugation forces significantly increased the number of platelets, leukocytes, and growth factors. Recently, evaluation of the centrifugation angle revealed greater entrapment of large cells, such as red blood cells, when centrifugation was changed from a fixed to a horizontal angle. Tissue bioengineering studies are allowing for significant advances in the process of obtaining blood components and enabling their use for tissue repair with greater predictability and less morbidity.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    创伤和感染后的组织修复一直是再生医学中的难题。水凝胶由于其生物相容性,已成为组织工程的重要支架材料之一。生物降解性和水溶性。尤其是,水凝胶的刚度是一个关键因素,影响间充质干细胞(MSCs)的形态及其分化。这一点的研究对组织工程领域具有重要意义。在这里,本文综述了不同硬度的水凝胶的设计及其对MSCs行为的影响。此外,介绍了水凝胶刚度对巨噬细胞表型的影响,然后讨论了巨噬细胞炎症反应表型改变与组织修复的关系。最后,展望了具有一定刚度的水凝胶在再生医学和组织工程中的应用前景。
    Tissue repair after trauma and infection has always been a difficult problem in regenerative medicine. Hydrogels have become one of the most important scaffolds for tissue engineering due to their biocompatibility, biodegradability and water solubility. Especially, the stiffness of hydrogels is a key factor, which influence the morphology of mesenchymal stem cells (MSCs) and their differentiation. The researches on this point are meaningful to the field of tissue engineering. Herein, this review focus on the design of hydrogels with different stiffness and their effects on the behavior of MSCs. In addition, the effect of hydrogel stiffness on the phenotype of macrophages is introduced, and then the relationship between the phenotype changes of macrophages on inflammatory response and tissue repair is discussed. Finally, the future application of hydrogels with a certain stiffness in regenerative medicine and tissue engineering has been prospected.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号